Persistent postural-perceptual dizziness: current approaches to diagnosis and treatment
https://doi.org/10.14412/2074-2711-2019-4-136-140
Abstract
The cause of persistent postural-perceptual dizziness (PPPD) is considered to be chronic dysfunction of the regulatory system for maintaining equilibrium in general and that of the vestibular system in particular, which causes a persistent sensation of dizziness and/or unsteadiness. The pathogenetic mechanisms of PPPD are associated with impaired adaptation to an acute vertigo or unsteadiness episode due to various causes (vestibular, lipothymic, or emotional).
Patients severely experience PPPD, which often leads to avoidant behavior and even disability. The timely diagnosis of this disorder and the use of right treatment, including vestibular rehabilitation, antidepressants, and cognitive behavioral therapy, are of great importance. Currently developed new treatments for PPPD are highly therapeutically effective. Among the medicines, Ginkgo biloba extract has been shown to be effective in improving vestibular compensation.
About the Authors
L. M. Antonenko
Department of Nervous System Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
11, Rossolimo St., Build. 1, Moscow 119021
Russian Federation
11, Rossolimo St., Build. 1, Moscow 119021
E. N. Zastenskaya
Department of Nervous System Diseases and Neurosurgery, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
11, Rossolimo St., Build. 1, Moscow 119021
Russian Federation
11, Rossolimo St., Build. 1, Moscow 119021
References
1. Parfenov VA, Golyk VA, Matsnev EI, et al. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study. PLoS One. 2017 Mar 30;12(3):e0174114. doi: 10.1371/journal.pone.0174114. eCollection 2017.
2. Popkirov S, Staab JP, Stone J. Persistent postural-perceptual dizziness (PPPD): A common, characteristic and treatable cause of chronic dizziness. Pract Neurol. 2018 Feb;18(1):5-13. doi: 10.1136/practneurol-2017-001809. Epub 2017 Dec 5.
3. Lee JO, Lee ES, Kim JS, et al. Altered brain function in persistent postural perceptual dizziness: A study on resting state functional connectivity. Hum Brain Mapp. 2018 Aug;39(8): 3340-3353. doi: 10.1002/hbm.24080. Epub 2018 Apr 15.
4. Antonenko LM. Psychogenic dizziness. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2016;8(2):50-4 (In Russ.) doi: 10.14412/2074-2711-2016-2-50-54
5. Antonenko LM, Parfenov VA. Drug therapy for peripheral vestibular vertigo. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(1):106-10. (In Russ.) doi: 10.14412/2074-2711-2017-1-106-110
6. Xue H, Chong Y, Jiang ZD, et al. Etiological analysis on patients with vertigo or dizziness. Zhonghua Yi Xue Za Zhi. 2018 Apr 24;98(16): 1227-1230. doi: 10.3760/cma.j.issn.0376-2491.2018.16.008.
7. Dieterich M, Staab JP. Functional dizziness: From phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness. Curr Opin Neurol. 2017 Feb;30(1): 107-113. doi: 10.1097/WCO.0000000000000417.
8. Dieterich M, Staab JP, Brandt T. Functional (psychogenic) dizziness. Handb Clin Neurol. 2016;139:447-468. doi: 10.1016/B978-0-12-801772-2.00037-0.
9. Staab JP, Eckhardt-Henn A, Horii A, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the classification of vestibular disorders of the bЗrЗny society. J Vestib Res. 2017;27(4):191-208. doi: 10.3233/VES-170622.
10. Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the International Classification of Vestibular Disorders. Neurol Clin. 2015 Aug; 33(3):541-50, vii. doi: 10.1016/j.ncl.2015.04.010.
11. Staab JP, Ruckenstein MJ. Expanding the differential diagnosis of chronic dizziness. Arch Otolaryngol Head Neck Surg. 2007 Feb;133(2): 170-6.
12. Stone J. Functional neurological disorders: The neurological assessment as treatment. Pract Neurol. 2016 Feb;16(1):7-17. doi: 10.1136/practneurol-2015-001241. Epub 2015 Dec 29.
13. Spitzer RL, Kroenke K, Williams JB, Lö we B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med.2006 May 22;166(10):1092-7.
14. Wuehr M, Brandt T, Schniepp R. Distracting attention in phobic postural vertigo normalizes leg muscle activity and balance. Neurology. 2017 Jan 17;88(3):284-288. doi: 10.1212/WNL.0000000000003516. Epub 2016 Dec 14.
15. Popkirov S, Stone J, Holle-Lee D. Treatment of Persistent Postural-Perceptual Dizziness (PPPD) and Related Disorders Curr Treat Options Neurol. 2018 Oct 13;20(12):50. doi: 10.1007/s11940-018-0535-0.
16. Trinidade A, Goebel JA. Persistent posturalperceptual dizziness - a systematic review of the literature for the balance specialist. Otol Neurotol. 2018 Dec;39(10):1291-1303. doi: 10.1097/MAO.0000000000002010.
17. Horii A. Anxiety, depression, and persistent postural perceptual dizziness: International classification of vestibular disorders by Barany Society. Equilibrium Research. 2017;76(4):316-22. doi: 10.3757/jser.76.316
18. Esin RG, Khairullin IKh, Mukhametova ER, Esin OR. Persistent postural-perceptual dizziness. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(4):28-33. (In Russ.)
19. Spiegel R, Rust H, Baumann T, et al. Treatment of dizziness: an interdisciplinary update. Swiss Med Wkly. 2017 Dec 27; 147:w14566. doi: 10.4414/smw.2017.14566. eCollection 2017.
20. Heinrichs N, Edler C, Eskens S, et al. Predicting Continued Dizziness After an Acute Peripheral Vestibular Disorder. Psychosom Med. 2007 Sep-Oct;69(7):700-7. Epub 2007 Aug 31. doi: 10.1097/psy.0b013e318151a4dd
21. Balaban C, Furman J, Staab J. Threat Assessment and Locomotion: Clinical Applications of an Integrated Model of Anxiety and Postural Control. Semin Neurol. 2013 Jul; 33(3):297-306. doi: 10.1055/s-0033-1356462. Epub 2013 Sep 21.
22. Best C, Eckhardt-Henn A, Tschan R, Dieterich M. Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. J Neurol. 2009 Jan;256(1):58-65. doi: 10.1007/s00415-009-0038-8. Epub 2009 Feb 7.
23. Yu YC, Xue H, Zhang YX, Zhou J. Cognitive Behavior Therapy as Augmentation for Sertraline in Treating Patients with Persistent Postural-Perceptual Dizziness. Biomed Res Int. 2018 Mar 7;2018:8518631. doi: 10.1155/2018/8518631. eCollection 2018.
24. Sohsten E, Bittar RS, Staab JP. Posturographic profile of patients with persistent postural-perceptual dizziness on the sensory organization test. J Vestib Res. 2016 Jul 2;26(3): 319-26. doi: 10.3233/VES-160583.
25. Mü ller WE, Chatterjee SS. Cognitive and other behavioral effects of EGb 761® in animal models. Pharmacopsychiatry. 2003 Jun;36 Suppl1:S24-31.
26. Sakakibara H, Ishida K, Grundmann O, et al. Antidepressant Effect of Extracts from Ginkgo biloba Leaves in Behavioral Models. Biol. Biol Pharm Bull. 2006 Aug;29(8):1767-70. doi: 10.1248/bpb.29.1767 б
27. Bachinskaya N, Hoerr R, Ihl R. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761®.Findings from a randomized controlled trial. Neuropsychiatr Dis Treat. 2011;7:209-15. doi: 10.2147/NDT.S18741. Epub 2011 Apr 20.
28. Hoerr R. Behavioural and psychological symptoms of dementia (BPSD): effects of EGb 761®. Pharmacopsychiatry. 2003 Jun;36 Suppl 1: S56-61. doi: 10.1055/s-2003-40451
29. Hoerr R, Nacu A. Neuropsychiatric symptoms in dementia and the effects of Ginkgo biloba extract EGb 761® treatment: additional results from a 24-week randomized, placebocontrolled trial. Open Access Journal of Clinical Trials. 2016; Jan;2016(8):1-6. doi:10.2147/OAJCT.S93531
30. Antonenko LM. Diagnosis, treatment, and rehabilitation in patients with dizziness and cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2017;9(3):76-80. (InRuss.) doi: 10.14412/2074-2711-2017-3-76-80
Review
For citations:
Antonenko L.M., Zastenskaya E.N. Persistent postural-perceptual dizziness: current approaches to diagnosis and treatment. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):136-140. (In Russ.) https://doi.org/10.14412/2074-2711-2019-4-136-140
Views: 5234
Email this article 